Mierzwa Michelle L, Barrett William L, Gluckman Jack L
Division of Radiation Oncology, Barrett Center for Cancer Prevention, Treatment and Research, 234 Goodman Street, University of Cincinnati Medical Center, PO Box 670757, Cincinnati, Ohio 45267-0757, USA.
Head Neck. 2003 May;25(5):412-5. doi: 10.1002/hed.10200.
Surgical resection and corticosteroid therapy have traditionally been the preferred methods of treatment for orbital hemangioma. Radiation therapy is not usually indicated because of the potential for ocular complications. With modern radiation techniques, however, patients may experience substantial clinical improvement without significant radiation-induced morbidity.
A case of unresectable, recurrent orbital hemangioma is described. The clinical presentation, management protocol using radiation therapy, and 5-year follow-up are reviewed.
The patient was initially seen with left orbital pain, diplopia, proptosis, and conjunctival edema caused by a recurrent left orbital hemangioma after failed previous surgery. CT scan and angiogram revealed a large, irregular, multilocular mass in the left orbit consistent with hemangioma. The patient was treated with a total of 2000 cGy in 10 treatments. Five-year follow-up revealed a stable, regressed hemangioma with no radiation complications.
Radiation therapy may be used if appropriately indicated for function-threatening orbital hemangioma.
传统上，手术切除和皮质类固醇疗法一直是眼眶血管瘤的首选治疗方法。由于存在眼部并发症的可能性，通常不采用放射治疗。然而，借助现代放射技术，患者可能在无明显放射诱发的发病率的情况下获得显著的临床改善。
描述了一例无法切除的复发性眼眶血管瘤病例。回顾了临床表现、使用放射治疗的管理方案以及5年随访情况。
该患者最初因先前手术失败后复发性左眼眶血管瘤出现左眼眶疼痛、复视、眼球突出和结膜水肿。CT扫描和血管造影显示左眼眶有一个大的、不规则的多房性肿块，与血管瘤相符。该患者共接受了10次治疗，总剂量为2000 cGy。5年随访显示血管瘤稳定且缩小，无放射并发症。
对于威胁功能的眼眶血管瘤，如果有适当指征，可使用放射治疗。
